GE HealthCare Technologies Inc (GEHC, Financial) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus estimate for Q4 2024 revenue is $5.33 billion, and the earnings are expected to come in at $1.31 per share. The full year 2024's revenue is expected to be $19.69 billion and the earnings are expected to be $4.09 per share. More detailed estimate data can be found on the Forecast page.
Revenue estimates for GE HealthCare Technologies Inc (GEHC) have declined from $19.69 billion to $19.69 billion for the full year 2024 and declined from $20.55 billion to $20.38 billion for 2025 over the past 90 days. Earnings estimates for GE HealthCare Technologies Inc (GEHC) have declined from $4.11 per share to $4.09 per share for the full year 2024 and increased from $4.43 per share to $4.45 per share for 2025 over the past 90 days.
In the previous quarter of 2024-09-30, GE HealthCare Technologies Inc's (GEHC) actual revenue was $4.86 billion, which missed analysts' revenue expectations of $4.87 billion by -0.11%. GE HealthCare Technologies Inc's (GEHC) actual earnings were $1.02 per share, which beat analysts' earnings expectations of $0.996 per share by 2.41%. After releasing the results, GE HealthCare Technologies Inc (GEHC) was up by 2.26% in one day.
Based on the one-year price targets offered by 18 analysts, the average target price for GE HealthCare Technologies Inc (GEHC) is $96.79 with a high estimate of $110.00 and a low estimate of $74.00. The average target implies an upside of 11.21% from the current price of $87.03.
Based on GuruFocus estimates, the estimated GF Value for GE HealthCare Technologies Inc (GEHC, Financial) in one year is $0.00, suggesting a downside of -100% from the current price of $87.03.
Based on the consensus recommendation from 21 brokerage firms, GE HealthCare Technologies Inc's (GEHC, Financial) average brokerage recommendation is currently 2.1, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。